Klug GM - Search Results

1

Increased proportions of C1 truncated prion protein protect against cellular M1000 prion infection.

Lewis V, Hill AF, Haigh CL, Klug GM, Masters CL, Lawson VA, Collins SJ. Lewis V, et al. Among authors: klug gm. J Neuropathol Exp Neurol. 2009 Oct;68(10):1125-35. doi: 10.1097/NEN.0b013e3181b96981. J Neuropathol Exp Neurol. 2009. PMID: 19918124

2

Beta-amyloid protein oligomers induced by metal ions and acid pH are distinct from those generated by slow spontaneous ageing at neutral pH.

Klug GM, Losic D, Subasinghe SS, Aguilar MI, Martin LL, Small DH. Klug GM, et al. Eur J Biochem. 2003 Nov;270(21):4282-93. doi: 10.1046/j.1432-1033.2003.03815.x. Eur J Biochem. 2003. PMID: 14622293 Free article.

3

Australian sporadic CJD analysis supports endogenous determinants of molecular-clinical profiles.

Lewis V, Hill AF, Klug GM, Boyd A, Masters CL, Collins SJ. Lewis V, et al. Among authors: klug gm. Neurology. 2005 Jul 12;65(1):113-8. doi: 10.1212/01.wnl.0000167188.65787.a0. Neurology. 2005. PMID: 16009895

4

Extended period of asymptomatic prion disease after low dose inoculation: assessment of detection methods and implications for infection control.

Collins SJ, Lewis V, Brazier MW, Hill AF, Lawson VA, Klug GM, Masters CL. Collins SJ, et al. Among authors: klug gm. Neurobiol Dis. 2005 Nov;20(2):336-46. doi: 10.1016/j.nbd.2005.03.014. Neurobiol Dis. 2005. PMID: 16242640

5

Correlative studies support lipid peroxidation is linked to PrP(res) propagation as an early primary pathogenic event in prion disease.

Brazier MW, Lewis V, Ciccotosto GD, Klug GM, Lawson VA, Cappai R, Ironside JW, Masters CL, Hill AF, White AR, Collins S. Brazier MW, et al. Among authors: klug gm. Brain Res Bull. 2006 Jan 30;68(5):346-54. doi: 10.1016/j.brainresbull.2005.09.010. Epub 2005 Oct 5. Brain Res Bull. 2006. PMID: 16377442

6

Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease.

Collins SJ, Sanchez-Juan P, Masters CL, Klug GM, van Duijn C, Poleggi A, Pocchiari M, Almonti S, Cuadrado-Corrales N, de Pedro-Cuesta J, Budka H, Gelpi E, Glatzel M, Tolnay M, Hewer E, Zerr I, Heinemann U, Kretszchmar HA, Jansen GH, Olsen E, Mitrova E, Alpérovitch A, Brandel JP, Mackenzie J, Murray K, Will RG. Collins SJ, et al. Among authors: klug gm. Brain. 2006 Sep;129(Pt 9):2278-87. doi: 10.1093/brain/awl159. Epub 2006 Jul 1. Brain. 2006. PMID: 16816392 Free article.

7

Molecular typing of PrPres in human sporadic CJD brain tissue.

Lewis V, Klug GM, Hill AF, Collins SJ. Lewis V, et al. Among authors: klug gm. Methods Mol Biol. 2008;459:241-7. doi: 10.1007/978-1-59745-234-2_16. Methods Mol Biol. 2008. PMID: 18576159

8

Enhanced geographically restricted surveillance simulates sporadic Creutzfeldt-Jakob disease cluster.

Klug GM, Wand H, Boyd A, Law M, Whyte S, Kaldor J, Masters CL, Collins S. Klug GM, et al. Brain. 2009 Feb;132(Pt 2):493-501. doi: 10.1093/brain/awn303. Epub 2008 Nov 28. Brain. 2009. PMID: 19042933

9

No evidence for prion protein gene locus multiplication in Creutzfeldt-Jakob disease.

Collins SJ, Schuur M, Boyd A, Lewis V, Klug GM, McGlade A, van Oosterhout A, Breedveld G, Oostra BA, Masters C, Van Duijn CM. Collins SJ, et al. Among authors: klug gm. Neurosci Lett. 2010 Mar 12;472(1):16-8. doi: 10.1016/j.neulet.2010.01.043. Epub 2010 Jan 25. Neurosci Lett. 2010. PMID: 20105449

10

The prion protein preference of sporadic Creutzfeldt-Jakob disease subtypes.

Klemm HM, Welton JM, Masters CL, Klug GM, Boyd A, Hill AF, Collins SJ, Lawson VA. Klemm HM, et al. Among authors: klug gm. J Biol Chem. 2012 Oct 19;287(43):36465-72. doi: 10.1074/jbc.M112.368803. Epub 2012 Aug 28. J Biol Chem. 2012. PMID: 22930754 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results